Valuation: InspireMD, Inc.

Market Cap 41.21M 35.59M 33.49M 30.44M 57.24M 3.95B 58.08M 393M 154M 1.97B 155M 151M 6.58B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 41.21M 35.59M 33.49M 30.44M 57.24M 3.95B 58.08M 393M 154M 1.97B 155M 151M 6.58B EV / Sales 2026 *
4.31x
EV / Sales 2027 * 2.01x
Free-Float
80.78%
Yield 2026 *
-
Yield 2027 * -
1 day+0.06%
1 week+3.25%
Current month+35.43%
1 month+25.06%
3 months-16.16%
6 months-49.12%
Current year-50.54%
1 week 0.81
Extreme 0.8102
1.02
1 month 0.65
Extreme 0.65
1.02
Current year 0.63
Extreme 0.63
1.98
1 year 0.63
Extreme 0.63
2.56
3 years 0.63
Extreme 0.63
3.85
5 years 0.63
Extreme 0.63
5.06
10 years 0.63
Extreme 0.63
115,237.62
Manager TitleAgeSince
Chief Executive Officer 62 2019-12-31
Director of Finance/CFO 58 2025-06-24
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 71 2017-06-01
Director/Board Member 68 2013-02-06
Director/Board Member 62 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
5/11/26 Buy

Chairman

10,000 0.0213%
5/8/26
Osiris Investment Partners LLC
OtherCompany 0 0%
1/15/26 Sell

Executive/Senior Manager

61,194 0.1444%
Change 5-day change 1-year change 3-year change Capi.($)
+0.06%+3.25%-64.65%-73.16% 41.21M
+1.33%-3.52%-11.98%+20.87% 127B
+2.07%+0.23%-17.62%+3.83% 12.41B
-0.75%+0.99%+105.32%+155.99% 10.94B
-2.05%-7.70%-46.42%-68.85% 4.45B
+0.11%-0.45%-25.69%+42.67% 2.67B
-0.70%-3.11%-21.90%-14.22% 1.66B
+0.08%-3.52%-35.42%-73.65% 1.65B
-1.01%-3.26%-35.17%-36.93% 1.64B
Average -0.09%-1.21%-17.06%-4.83% 18.08B
Weighted average by Cap. +1.12%-3.47%-6.27%+24.64%

Financials

2026 *2027 *
Net sales 9.56M 8.26M 7.77M 7.06M 13.28M 916M 13.48M 91.13M 35.72M 458M 35.89M 35.12M 1.53B 20.54M 17.74M 16.69M 15.17M 28.53M 1.97B 28.95M 196M 76.73M 984M 77.12M 75.44M 3.28B
Net income - -
Net Debt - -
Logo InspireMD, Inc.
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
Employees
127
Date Price Change Volume
26-08-18 US$0.8803 +0.06% 64,639
26-08-17 US$0.8798 -10.44% 528,594
26-08-14 US$0.9824 +16.94% 437,866
26-08-13 US$0.8401 -2.31% 51,827
26-08-12 US$0.8600 +0.87% 86,801
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.8798USD
Average target price
3.667USD
Spread / Average Target
+316.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NSPR Stock